| Literature DB >> 33507972 |
Júlio Menta de Almeida1, Felipe Oliveira Nunes2, Lígia Fernanda Ceole3, Tabata D'Maiella Freitas Klimeck3, Letícia Alves da Cruz1, Danilo Tófoli2, Beatriz Santana Borges3, Walmir Silva Garcez2, Inês Aparecida Tozetti1, Lia Carolina Soares Medeiros3, Fernanda Rodrigues Garcez2, Alda Maria Teixeira Ferreira1.
Abstract
Butanolides have shown a variety of biological effects including anti-inflammatory, antibacterial, and antiprotozoal effects against certain strains of Trypanosoma cruzi. Considering the lack of an effective drug to treat T. cruzi infections and the prominent results obtained in literature with this class of lactones, we investigated the anti-T. cruzi activity of five butanolides isolated from two species of Lauraceae, Aiouea trinervis and Mezilaurus crassiramea. Initially, the activity of these compounds was evaluated on epimastigote forms of the parasite, after a treatment period of 4 h, followed by testing on amastigotes, trypomastigotes, and mammalian cells. Next, the synergistic effect of active butanolides against amastigotes was evaluated. Further, metacyclogenesis inhibition and infectivity assays were performed for the most active compound, followed by ultrastructural analysis of the treated amastigotes and trypomastigotes. Among the five butanolides studied, majoranolide and isoobtusilactone A were active against all forms of the parasite, with good selectivity indexes in Vero cells. Both butanolides were more active than the control drug against trypomastigote and epimastigote forms and also had a synergic effect on amastigotes. The most active compound, isoobtusilactone A, which showed activity against all tested strains inhibited metacyclogenesis and infection of new host cells. In addition, ultrastructural analysis revealed that this butanolide caused extensive damage to the mitochondria of both amastigotes and trypomastigotes, resulting in severe morphological changes in the infective forms of the parasite. Altogether, our results highlight the potential of butanolides against the etiologic agent of Chagas disease and the relevance of isoobtusilactone A as a strong anti-T. cruzi drug, affecting different events of the life cycle and all evolutionary forms of parasite after a short period of exposure.Entities:
Year: 2021 PMID: 33507972 PMCID: PMC7842926 DOI: 10.1371/journal.pone.0245882
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240